Advertisement

Evidence that the Human Hepatocyte Contain and Secrete Factor VIII

  • J. Ingerslev
  • B. S. Christiansen
  • L. Heickendorff
  • C. Munck  Petersen
Conference paper

Zusammenfassung

Human factor VIII (procoagulant: VIII:C, coagulant antigen: VIII:Ag) is a hetero-dimeric plasma protein consisting of 80 kDa and 90–120 kDa polypeptides linked by divalent metal-ion bridges. In plasma F. VIII circulates non-covalently bound to von Willebrand factor. In spite of recent advances in biochemistry of F. VIII, the specific cellular origin of this protein is still obscure. In the past, several animal studies have failed to clearly indicate the organ most important for F. VIII production (Review 1). Recently it was shown that liver transplantation to a haemophilia A patient resulted in normalization of plasma VIII:C [2]. The molecular cloning of human factor VIII was performed using A DNA library from human liver [3]. Two attempts to demonstrate VIII: Ag in liver tissue biopsies gave inconsistent results, although the same monoclonal antibody was used. In the first study [4] VIII: Ag immune reactivity was disclosed to liver sinusoideal lining cells, whereas the second study [5] demonstrated VIII: Ag in endoplasmatic reticulum of hepatocytes, the site of protein synthesis, but some VIII:Ag reactivity was also seen in sinusoideal cells. It therefore is reasonably assumed that F. VIII synthesis takes place in the liver. The present investigation, performed on isolated and cultivated human hepatocytes, indicates that the hepatocyte is a production site for F. VIII.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barrow EM, Graham JV (1974) Blood coagulation factor VIII (antihemophilic factor): with comments on von Willebrand’s disease and Christmas disease. Physiological Rev 53:23–74Google Scholar
  2. 2.
    Lewis JH, Bontempo FA, Spero JA, Ragni MV, Startzl TE (1985) Liver transplantation in a hemophiliac. New Engl J Med 312:1189–1190PubMedGoogle Scholar
  3. 3.
    Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Baton DE, Vehar GA, Capon CL, Lawn RM (1984) Characterization of the human factor VIII gene. Nature 312:326–330PubMedCrossRefGoogle Scholar
  4. 4.
    Stel HV, van der Kwast THH, Veerman ECI. Detection of factor VIII/coagulant antigen in human liver tissu. Nature 303:530–532.Google Scholar
  5. 5.
    Zelechowska MG, Mourik JA, Brodniewicz-Proba T (1985) Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 312:729–730CrossRefGoogle Scholar
  6. 6.
    Ingerslev J, Stenbjerg S (1986) Brit. J. Enzyme linked immunosorbent assay (ELISA) for the measurement of factor VIII coagulant antigen (CAg) using haemophilic antibodies. Haematol 62:325–332Google Scholar
  7. 7.
    Andersson L-O, Forsman N, Huang K, Larsen K, Lundin A, Pavlu B, Sandberg H, Sewerin K, Smart J (1983) Isolation and characterization of human factor VII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma. Proc Natl Acad Sci USA 83:2879–2983Google Scholar
  8. 8.
    Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ (1986) A large region (≃ 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc Natl Acad Sci USA 83:5939–5942PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • J. Ingerslev
    • 1
  • B. S. Christiansen
    • 1
  • L. Heickendorff
    • 1
  • C. Munck  Petersen
    • 1
  1. 1.AarhusDenmark

Personalised recommendations